[HTML][HTML] Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A Maurya, AK Singh, G Mishra, K Kumari… - … Medicine and Applied …, 2019 - akjournals.com
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

[PDF][PDF] Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A MAURYA, AK SINGH, G MISHRA, K KUMARI, A RAI… - researchgate.net
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A Maurya, AK Singh, G Mishra, K Kumari… - … Medicine and Applied …, 2019 - cir.nii.ac.jp
抄録< jats: p> Since the development of first lipid-based nanocarrier system, about 15% of
the present pharmaceutical market uses nanomedicines to achieve medical benefits …

[PDF][PDF] Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A MAURYA, AK SINGH, G MISHRA, K KUMARI, A RAI… - scienceopen.com
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

[PDF][PDF] Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A MAURYA, AK SINGH, G MISHRA, K KUMARI, A RAI… - pdfs.semanticscholar.org
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A Maurya, AK Singh, G Mishra, K Kumari, A Rai… - 2019 - hero.epa.gov
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review.

A Maurya, AK Singh, G Mishra, K Kumari… - … Medicine & Applied …, 2019 - europepmc.org
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A MAURYA, AK SINGH, G MISHRA, K KUMARI, A RAI… - akjournals.com
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A Maurya, AK Singh, G Mishra… - … medicine & applied …, 2019 - pubmed.ncbi.nlm.nih.gov
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …

[HTML][HTML] Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

A Maurya, AK Singh, G Mishra, K Kumari… - … Medicine & Applied …, 2019 - ncbi.nlm.nih.gov
Since the development of first lipid-based nanocarrier system, about 15% of the present
pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is …